Fdaapproved for adjunctive use with the cervistatm hpv hr test in patients with ascus cervical cytology results, to assess the presence or absence of highrisk types 16 andor 18. Evaluation of the new york state human papilloma virus. Combining immune checkpoint blockade and tumorspecific. The cervista hpv hr test uses the invader chemistry, a signal amplification method for detection of specific nucleic acid sequences. We have evaluated cervista hpv hr for papillomavirus detection in 65 samples previously borderline negative by the hybrid capture method digene, using innolipa and sequencing as confirmatory. Cervical cancer screening american family physician. Department of pathology specimen submission procedure for gynecologic cytology and hpv testing thinprep pap test, cervista high risk hpv test and hpv 1618 genotyping test purpose to establish collection methods for pap testhpv specimens from the female genital tract.
Hpv vaccine prevents infection from the hpv types that cause over 90% of these cancers. A text file is automatically generated and saved for each tape. Human papillomavirus hpv vaccines, who should and should not get hpv vaccine, benefits, possible reactions after vaccination, what hpv is and who can get it, and what happens after infection. Human papillomavirus hpv vaccines healthlinkbc file 101b. Pooled detection by hybrid capture ii hpv dna test, cervista hpv dna test, and aptima hpv mrna test specific detection by cobas hpv dna test other. The cervista hpv hr test uses the invader chemistry, a signal amplification method for detection of. The five fdaapproved hpv assays medical laboratory observer. Human papillomavirus hpv infection and genital warts. Cervista high risk hpv typing and cervista hpv 1618 genotyping. Highrisk hr human papillomavirus hpv testing is important in cervical cancer screening for triage to colposcopy.
Cervical cancer is thus far the most common human papillomavirus hpv related cancer. Cervista hpv hr testing of head and neck fna specimens is a valid option for determining hpv1618 status in patients with oropharyngeal carcinoma. Cervista hpv 1618 is a qualitative, in vitro diagnostic test for the detection of dna from two highrisk hpv types. In women 30 years and older the test may be used adjunctively with the cervista hpv hr test in combination with cervical cytology to assess the presence or absence of specific highrisk hpv. To validate the efficacy of seeplex hpv4a ace for the detection of highrisk hr human papillomavirus hpv and hpv 16 andor hpv 18 genotypes as compared to the pcr method and the cervista hpv assays in cervical swab samples. The clinical performance of the cervista hpv hr test was assessed relative to. Anogenital hpv is associated with virtually all cancers of the cervix. The final interpretation was based on the cervista hpv 1618 retest value, and equivocal results were considered negative according to the manufacturers guidelines.
This is the summary and evaluation of the graded new york state proficiency test for human papilloma virus hpv determination from march 2011. Use of cervista hpv hr assay for detection of human. Association between human papillomavirus dna and temporal. Cervical specimens that may be tested with the cervista hpv 1618 test include the. Human papillomavirus hpv is the most common sexually transmitted disease worldwide, with more than 100 types of hpv identified. This method uses two types of isothermal reactions. Detection of hpv using the cervistatm hpv hr test does not differentiate hpv types. Cervista hpv hr test for cervical cancer screening prbb.
The dna was extracted from residual liquid cytology. Approximately 20 million americans are currently infected. Add 10 l of each control and sample dna to three wells of a 96well plate as indicated in. Surveillance manual hpv vaccine preventable diseases cdc. Human papillomavirus hpv human papillomavirus, or hpv, is the most common sexually transmitted infection sti in the united states. The cervista hpv hr test was the second hr hpv assay approved by the fda in 2009 and is a qualitative test that uses three separate oligonucleotide mixtures a5a6 pool hpv 51, 56, and 66, a7 pool 18, 39, 45, 59, and 68, and a9 pool hpv 16, 31, 33, 35, 52, and 58 depending on the correlation among 14 types of hr hpv dna gene sequences. Also, keep in mind insurances dont cover the test, as a screening test, unless you are between 3065. While a variety of human papillomavirus hpv tests and surrogate markers are available, currently there is no consensus on the best detection methods that should be used to identify hpv. The study, shenccast ii, is a major cervical cancer screening trial conducted in china to evaluate the performance of hpv assays, among other endpoints. To establish a foundation for hpv based screening and vaccination programs in china, we investigated the most recent hpv prevalence and genotypic. Indeed, together they account for 7080% of cervical cancers, 4050% of vulval and oropharyngeal cancers and 7080% of anal cancers. Of these, 64 were highgrade cervical intraepithelial. Molecular diagnostics of human papillomavirus laboratory.
To test the performance of the cervista hpv hr test for cervical screening. Comparing the cervista hpv hr test and hybrid capture 2 assay. Find local cervista hpv test resources for the top u. Those that persist for 2 years or longer may lead to the development of precancerous lesions and cxca. Available tests hpv types detected identifies hpv type hybrid capture 2 high and low risk panels request high risk only no cervista hpv hr high risk no add on test for 16 and 18 cobas hpv test high risk yes for 16 and 18 aptima hpv mrna assay high risk no add on test for 16, 18, and 45 asccp. The cervista tm hpv 1618 test is an in vitro diagnostic test for the qualitative detection of dna from human papillomavirus hpv type 16 and type 18 in cervical specimens. Cervista hpv hr test for cervical cancer screening. To estimate the highrisk human papillomavirus hrhpv prevalence in a hospitalbased population using the cervista and to determine the clinical value and significance of cervista for. A report with your laboratorys score and grade will be sent separately to you. Highrisk human papillomavirus hr hpv testing has been shown to be a valuable tool in cervical cancer screening for the detection of cervical precancer and cancer. The cervista hpv 1618 test is not intended for use as a screening device for pap normal women under age 30 and is not intended to substitute for regular pap screening. Cancer often takes years, even decades, to develop after a person gets hpv. The results of this test are not intended to prevent women from proceeding to colposcopy. Cervista hpv hr test and cervista hpv 1618 test the cervista hpv hr is designed for detection of 14 hpv types i.
The main causative agent for the disease is human papilloma virus hpv. Evaluation of the new york state human papilloma virus hpv proficiency test april 20141 dear laboratory director. Worldwide, the most common highrisk hr hpv are 1618, and approximately 70% of cervical cancers cc are due to infection by these genotypes. The study group consisted of 22 cases of histologically positivebiopsy confirmed gca. Pdf use of cervista hpv hr assay for detection of human. Hta and mta lab automation technology serves high, mid and low volume lab segments recent approvals in u. Human papillomavirus hpv is the most common viral infection of female reproductive tracts. The diagnostic performance of the widelyused cervista hpv hr test was. Use of cervista hpv hr assay for detection of human papillomavirus in samples with hybrid capture borderline negative results. The cervista tm hpv 1618 test uses the invader chemistry, a signal amplification method for detection of specific nucleic acid sequences. This testing is performed inhouse using the remaining fluid in the thinprep pap test vial.
Clinical experience with the cervista hpv hr assay ncbi. A populationbased observational study comparing cervista and. Males are at risk for hpv and related diseases, too, so boys and young men are also recommended to be vaccinated. Cytology and cytology gynecologic laboratory services. Human papillomavirus hpv is the most common viral infection of the reproductive tract. Therefore, the cervista hpv hr test met the criterion of noninferiority set forth by the international guidelines, i. Testing for highrisk hr human papillomavirus hpv is a key component of current recommendations for cervical cancer screening. Pdf false positive cervical hpv screening test results. Also approved was the cervista hpv 1618 genotyping test. We examined 875 cervical samples by hc2 and cervista. Headtohead comparison of the rnabased aptima human. Typespecific highrisk hpv hrhpv infection is related to cervical carcinogenesis.
Hpv can cause cervical and other cancers including cancer of the vulva, vagina, penis, or anus. Human papillomavirus hpv is the most common sexually transmitted virus. Full text cervical cancer screening using the cervista highrisk. Cervista hpv test facts a subgroup of the human papillomaviruses hpvs are known to cause cancers of the uterine cervix and other genital areas, the socalled high risk hpvs. Nationwide prevalence of human papillomavirus infection and. To examine the relationship between human papillomavirus hpv and giant cell arteritis gca of the temporal artery. To exploit the prevalence of hpv genotypes 5258 in a chinese population, we evaluated algorithms that the use the cervista. Most hpv infections go away by themselves within 2 years. Pdf evaluation of the cervista hpv a9 group in screening. Analytical performance of cervista hpv 1618 genotyping test. Abstractthe diagnostic performance of the widelyused cervista hpv hr test was compared to the hybrid capture 2 hc2. Food and drug administration approved molecular methods for. Future strategies for cervical cancer screening will be based on hpv detection. Started in 1995, this collection now contains 6767 interlinked topic pages divided into a tree of 31 specialty books and 732 chapters.
Cervista hpv 1618, informing the clinician about the presence of highrisk types of hpv and a womans risk of developing cervical cancer. The control groups consisted of 21 histologically negative temporal artery biopsies and fifteen cases of vascular margins of nephrectomies. Objectives the cervista highrisk human papillomavirus hrhpv test was evaluated as a primary screening method for cervical cancer in women aged. Aug 01, 2010 read clinical validation of the cervista hpv hr and 1618 genotyping tests for use in women with ascus cytology, gynecologic oncology on deepdyve, the largest online rental service for scholarly research with thousands of academic publications available at your fingertips. There is a hpv test that has been on the market for years and is showing that it may be just as, if not more effective in detecting hpv. After a 10year lull in fda approval of hpv tests, in march 2009 the cervista hpv hr test third wave technologies, now hologic, bedford, ma was approved by the fda to detect 14 highrisk hpv types. Hpv testing for cervical cancer screening robert schlaberg, md, mph understand the role of hr hpv in cervical cancer development know the use of hr hpv testing in current cervical cancer screening guidelines be able to compare testing principles used in. Interpretation of the hpv results was done in accordance with the cervista hpv hr. Headtohead comparison of the rnabased aptima human papillomavirus hpv assay and the dnabased hybrid capture 2 hpv test in a routine screening population of women aged 30 to 60 years in germany. In addition, when hpv consensus primers targeted against hpv l1 are used for pcr, integrated forms of the virus may not be detected due to loss of portions of l1. We report a purely observational study evaluating hr hpv prevalences in residual liquidbased cytology lbc samples using both the cervista hpv hr test and the digene hybrid capture 2 highrisk hpv dna test hc2 in a sample. Available tests hpv types detected identifies hpv type hybrid capture 2 high and low risk panels request high risk only no cervista hpv hr high risk no add on test for 16 and 18 cobas hpv test high risk yes for 16 and 18 aptima hpv mrna assay high risk. Histopathologic followup results a total of 2119 of 3637 cases 58.
The cervistatm hpv hr test cannot determine the specific hpv type present. The history of the cervical cancer goes back to eighteenth century as the hpv infection is reported since 1800s. Human papillomavirus testing in men the journal of the. Cervista hpv 1618 test hologic, madison, wi digene hpv genotyping ps test, ruo. University of groningen innovative molecular markers for. Genprobe aptima hpv test cervista hpv hr cobas hpv test hc2 highrisk hpv dna test 1. Hpv 16 54% and hpv 18 21% account for the majority of cervical cancers worldwide5 nononcogenic types include. The final analysis of this arm of the study, which included 8,435 patients, showed. Amplification and genotyping of hpv16 and hpv18 cervista hpv 1618. Hpv manual for the surveillance of vaccinepreventable diseases human papillomavirus chapter 5 skip directly to site content skip directly to page options skip directly to az link centers for disease control and prevention. Cervista hpv hr is a diagnostic test for the detection of 14 highrisk human papillomavirus hpv types. About 80 percent of women will get at least one type of hpv at some point in their lifetime.
Hpv vaccines dont protect against all types of hpv, though, so women need to continue having pap tests and, as appropriate, hpv tests even after being vaccinated for hpv. Although many cancers are cured with initial treatment, recurrent cancer is frequently incurable and associated with relatively short survival. Full text cervical cancer screening using the cervista. Hpv vaccination was introduced as part of the childhood vaccination programme in 2008 and will probably save 400 lives per year. Cervical cancer is a growing and serious problem worldwide in women, but more acute in developing countries especially in indian subcontinent. Headneck cytopathology miscellaneous lesions topics. Hpv is spread through intimate skintoskin or sexual contact. The technology would be made available through general practitioners for women aged 30 years or more or for women who returned an. University of groningen clinical validation of the. Disclosure speaker for merck gardasil speaker for hologic thin prep and cervista. Cervista hpv assays for fineneedle aspiration specimens.
In addition, the cervista hpv 1618 test has been approved for two uses. Persistent infection by hr hpv is a necessary but not sufficient cause of this cancer, which develops over a long period through precursor lesions, which can be detected by. The cervistatm hpv hr test is an in vitro diagnostic test for the qualitative detection of dna from 14 highrisk human papillomavirus hpv types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 in cervical specimens. The cervista test is used to diagnose the presence of dna from the highrisk hpvs in cervical samples. In addition to the hc2 which was performed using the manual procedure, the other assays assessed were the realtime hr hpv assay abbott, the aptima hpv test hologic, the cervista hpv test hologic and the cobas 4800 hpv test roche, all used according to the manufacturers instructions. Inadequate specimen volume can interfere with our ability to provide hpv dna testing. Hpv infections are so common that nearly all men and women will get at least one type of hpv at some time in their lives. Human papillomavirus hpv is the cause of nearly all cervical cancers and most oropharyngeal, anal, penile, vulvar, and vaginal cancers. Pdf clinical validation of the cervista highrisk human. It can also cause cancer in the back of the throat, including the base of the tongue and tonsils called oropharyngeal cancer. Cervista hpv 1618 is a qualitative, in vitro diagnostic test for the detection of dna from two highrisk hpv. The persistent infection of highrisk hpv hrhpv is associated with cervical cancer.
Detection of hpv using the cervista hpv hr test does not differentiate hpv types and cannot evaluate. The prevalence of hrhpv infection varies geographically, which might reflect the epidemiological characteristics of cervical cancer among different populations. It usually takes more than 10 years for precancerous lesions caused by hpv. Cervista hpv 1618 test results should be interpreted alongside, or as a followup to, a cervista hpv hr test result, adjunctively with cytology. The cervista hpv 1618 test uses the invader chemistry, a signal amplification method for detection of specific nucleic acid sequences. Cervista hpv hr test hologic, san diego, ca, the cobas hpv test.
Clinical validation of the cervista hpv hr test according to the. In conclusion, the specificity of the cervista hpv hr test could be improved. Hologic massachusetts, usa provides the cervista hpv 1618 with the aim of identifying two of the viral strains of human papillomavirus hpv that are associated with highgrade cervical cancer. It is usually spread through vaginal, oral, or anal sex. Why do you feel you need, specifically,the cervista hpv test. Cervista hpv hr is a qualitative, in vitro diagnostic test for the detection of dna from 14 high risk hpv types, namely, types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. Evaluation of commercial hpv assays in the context of post. Hpvassociated cancers and precancers 2015 std treatment. Pdf agestratified performance of the cervista hpv 1618. Emerging biomarkers and clinical significance of hpv. Pdf cervical cancer screening using the cervista highrisk. Learn about positive test results, hpv and cancer, and hpv testing guidelines. Agestratified performance of the cervista hpv 1618 genotyping test in women with ascus cytology. Comparison of the seeplex hpv4a ace and the cervista hpv.
Herein is described our clinical experience using cervista hpv hr, a testing platform recently approved by the us food and drug administration for clinical use. Hpv test cervista human papillomavirus infection test in. This is the summary and evaluation of the new york state proficiency test for human papilloma virus hpv from april 2014. Cervical cancer is thus far the most common human papillomavirus hpvrelated cancer. Evaluation of the new york state human papilloma virus hpv proficiency test event 311 march 20111 dear laboratory director. The hybrid capture 2 hc2 test is currently the most widely used method to screen for hpv.
1049 506 1574 618 123 1256 1368 1265 967 343 453 319 765 558 709 1061 1283 137 1625 837 1188 1184 1082 1532 1066 784 1108 1198 1254 1320 280 1225 1085 1031 1529 1023 317 595 235 310 341 1406 1475 219 736 392 282